Breaking News

08 December 2008
Biological antipsoriatics: Assessment of screening and monitoring tests during their use
08 October 2008
Defective killing of Staphylococcus aureus in atopic dermatitis is linked to decreased mobility of beta-defensin-3
29 August 2008
Desonide foam 0.05%; its safety in children with mild to moderate atopic dermatitis
28 August 2008
Clinical safety and efficacy of alefacept in chronic plaque psoriasis
27 August 2008
Support groups: their role in improving pruritus and quality of life of pediatric atopic dermatitis patients and their families
27 August 2008
Open-label pilot study of alefacept for pyoderma gangrenosum
26 August 2008
Possible role of prolactin in atopic dermatitis exacerbation
26 August 2008
Consensus statement on screening for latent tuberculosis infection in psoriasis patients treated with systemic or biological agents
25 August 2008
Nail psoriasis: cotherapy with clobetasol nail lacquer and tacalcitol ointment
22 August 2008
Inflammation and hypercoagulable state in adult psoriatic males
22 August 2008
Elevated platelet activation markers in atopic dermatitis
21 August 2008
Langerhans cells and prostaglandins: Contribution to etiology of various dermatoses
20 August 2008
Lessons about eczema from the International Study of Asthma and Allergies in Childhood
19 August 2008
Cardiovascular risk factors and psychiatric comorbidity in atopic eczema: A case-control study
18 August 2008
Ustekinumab, a human interleukin monoclonal antibody: its efficacy in psoriatic arthritis
18 August 2008
Measurement of family impact of skin disease: Validation of the Family Dermatology Life Quality Index
14 August 2008
Serum levels of pro- and antiinflammatory cytokines in psoriasis patients treated with the Goeckerman regimen
14 August 2008
Evaluation of IgA antibodies in dermatitis herpetiformis
13 August 2008
The vitamin D pathway: a novel target for dermal immune response?
13 August 2008
Polymorphisms of the IL12B and IL23R genes are associated with psoriasis